查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球彈性體輸液幫浦市場按類型、應用、終端用戶產業及地區分類－預測至2030年
市場調查報告書
商品編碼
1881226

全球彈性體輸液幫浦市場按類型、應用、終端用戶產業及地區分類－預測至2030年

Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 242 Pages | 訂單完成後即時交付

價格

全球彈性體輸液幫浦市場預計將從 2025 年的 11.5 億美元成長到 2030 年的 14.9 億美元，預測期內複合年成長率為 5.3%。

調查範圍
調查期 2023-2030
基準年 2024
預測期 2025-2030
單元 100萬美元
部分 類型、用途、最終用戶產業、地區
目標區域 北美洲、亞太地區、歐洲、中東和非洲、南美洲

隨著醫療專業人員和患者越來越依賴攜帶式非電子設備進行精準、持續的藥物輸注，彈性體輸液幫浦市場預計將穩定成長。在以患者為中心、可移動且簡化的輸註解決方案需求的推動下，腫瘤科、疼痛管理、麻醉科和居家醫療等領域的需求不斷成長，也促進了市場發展。這些設備無需電池或複雜的電路即可實現可靠、精準的藥物輸注，從而提高患者的活動能力和依從性。

彈性體輸液幫浦市場-IMG1

歐洲藥品管理局 (EMA)、美國食品藥物管理局(FDA) 等監管機構以及多個地區的衛生部門正在推出更嚴格的安全性、品質和生物相容性要求，迫使製造商開發新型多腔設計、流量控制系統和性能更優的彈性體。為減少醫療廢棄物，目前的研究進展包括即時劑量監測、與智慧監測系統整合以及使用可回收和環保材料。

“到2024年，疼痛管理將佔據彈性體輸液泵市場最大的佔有率。”

由於彈性體輸液幫浦在外科手術和慢性疼痛治療​​的廣泛應用，預計到2024年，疼痛管理將成為彈性體輸液幫浦市場最大的佔有率。這些輸液幫浦能夠持續、精準地輸送氫可酮和Fentanyl等止痛藥，進而有效緩解疼痛並縮短住院時間。其便攜性、易用性以及無需任何技術組件即可穩定輸送藥物的特性，使其成為住院和居家照護環境的理想選擇。外科手術數量的增加，以及對患者舒適度和活動能力的日益重視，正在推動這些輸液泵在疼痛治療領域的應用。

“到2024年，醫院在彈性輸液泵市場中佔據最大佔有率。”

預計到2024年，醫院將成為彈性體輸液幫浦市場最大的細分領域，這主要得益於各種治療中對可靠、持續給藥系統的巨大需求。這些輸液幫浦廣泛用於術後鎮痛、化療和抗生素給藥，無需依賴電子元件或外部電源即可實現持續輸注。其一次性無菌設計符合醫院的感染控制要求，並降低了交叉感染的風險和設備維護需求。此外，手術量的增加、對加速病患復健的重視以及病患對低成本輸液方案的偏好，都在推動醫院對彈性體輸液幫浦的採用。由於其操作簡便、安全可靠且精準，彈性體輸液幫浦已成為現代醫院患者照護的重要工具。

“2024年，北美在彈性體輸液泵區域市場佔據主導地位。”

2024年，彈性體輸液幫浦市場主要集中在北美，這主要得益於先進的醫療保健體系、尖端醫療設備的廣泛應用以及癌症、心血管疾病和糖尿病等慢性病盛行率的上升。該地區的大部分優勢歸功於強力的報銷和支持政策，以及日益普及的門診和居家醫療服務模式，所有這些因素都極大地推動了攜帶式、易於操作的輸液系統的發展。市場領導者保持著強勁的整體地位，有利因素依然穩固，為進一步鞏固市場領導地位創造了機會。此外，醫院和專科診所繼續使用彈性體輸液幫浦進行持續、耐受性良好的高劑量藥物輸注，用於疼痛管理和術後護理，從而提高患者舒適度並降低成本。

本報告分析了全球彈性體輸液幫浦市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

目錄

第1章 引言

第2章執行摘要

第3章 主要發現

  • 彈性體輸液幫浦市場的巨大機遇
  • 北美彈性體輸液幫浦市場按類型和國家分類
  • 按類型分類的彈性體輸液幫浦市場
  • 按應用分類的彈性體輸液幫浦市場
  • 按最終用途行業分類的彈性體輸液泵市場
  • 按國家/地區分類的彈性體輸液幫浦市場

第4章 市場概覽

  • 介紹
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 任務
  • 未滿足的需求和閒置頻段
    • 彈性體輸液幫浦市場未滿足的需求
    • 閒置頻段機會
  • 相互關聯的市場與跨產業機遇
    • 互聯市場
    • 跨職能機會
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟分析
    • 介紹
    • GDP趨勢與預測
  • 價值鏈分析
  • 生態系分析
  • 定價分析
    • 按類型分類的彈性體輸液幫浦平均銷售價格
    • 平均售價分析：按地區分類
  • 貿易分析
    • 出口方案（HS編碼901890）
    • 進口方案（HS編碼901890）
  • 重大會議和活動（2025-2026）
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措方案
  • 案例研究分析
  • 2025年美國關稅的影響：彈性體輸液幫浦市場
    • 介紹
    • 主要關稅稅率
    • 價格影響分析
    • 對國家的影響
    • 對終端用戶產業的影響

第6章：科技、專利、數位化和人工智慧應用帶來的策略顛覆

  • 主要新技術
    • 精密流量控制系統與多速率設計
    • 用於提高藥物穩定性的尖端材料
    • 用於壓力產生的彈性體膜
  • 互補技術
  • 鄰近技術
  • 技術/產品藍圖
    • 短期（2025-2027 年）| 基礎建設與早期商業化
    • 中期（2027-2030 年）| 擴張與整合
    • 長期（2030-2035 年及以後）| 成熟度與自主系統
  • 專利分析
    • 介紹
    • 調查方法
    • 彈性體輸液幫浦市場專利分析（2015-2024）
  • 未來應用
    • 用於遠端監測的數位健康整合
    • 拓展至獸醫門診護理
    • 提供生物製藥和基因療法等先進治療方案
    • 生物發光指示膜
  • 人工智慧/生成式人工智慧對彈性體輸液幫浦市場的影響
    • 主要應用案例和市場潛力
    • 彈性體輸液幫浦加工的最佳實踐
    • 人工智慧在彈性體輸液幫浦市場的應用案例研究
    • 相互關聯的相鄰生態系及其對市場參與者的影響
    • 彈性體輸液幫浦市場中客戶對生成式人工智慧應用的準備情況
  • 成功案例和實際應用
    • 密西根大學部署 DOSI-FUSER 彈性體輸注系統用於居家化療
    • 兒童居家化療（INTACT@HOME，加拿大）
    • 安寧療護和臨終症狀管理（加拿大安大略省南部）

第7章永續性與監管環境

  • 地方法規和合規性
    • 監管機構、政府機構和其他組織
    • 業界標準
  • 對永續性的承諾
  • 永續性影響和監管政策舉措
  • 認證、標籤和環境標準

第8章：顧客狀況與購買行為

  • 決策流程
  • 買方相關利益者和採購評估標準
    • 採購過程中的關鍵相關利益者
    • 採購標準
  • 招募障礙和內部挑戰
  • 各個終端用戶產業尚未滿足的需求
  • 市場盈利
    • 潛在收入
    • 成本動態
    • 利潤機會：按申請

9. 按類型分類的彈性體輸液幫浦市場

  • 介紹
  • 連續速率
  • 浮動利率

第10章 按應用分類的彈性體輸液幫浦市場

  • 介紹
  • 化療
  • 疼痛管理
  • 抗生素
  • 其他用途

11. 依終端用戶產業分類的彈性體輸液幫浦市場

  • 介紹
  • 醫院
  • 門診手術中心（ASC）
  • 居家照護環境
  • 其他終端用戶產業

12. 彈性體輸液幫浦市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

第13章 競爭格局

  • 概述
  • 主要參與企業的策略
  • 市佔率分析
  • 收入分析
  • 公司估值和財務指標
  • 產品/品牌對比
  • 企業評估矩陣：主要企業（2024）
  • 公司評估矩陣：Start-Ups/中小企業（2024 年）
  • 競爭場景

第14章：公司簡介

  • 主要企業
    • BAXTER
    • B. BRAUN SE
    • NIPRO
    • AVNS
    • VYGON
    • WOOYOUNG MEDICAL CO., LTD.
    • SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
    • AMBU A/S
    • PALEX
    • DAIKEN MEDICAL CO., LTD.
  • 其他公司
    • PROMECON GMBH
    • S&S MED
    • EPIC MEDICAL
    • MULTIMEDICAL SRL
    • TECNOLINE SPA
    • ZHEJIANG FERT MEDICAL DEVICE CO., LTD.
    • ACE MEDICAL
    • GAMASTECH SRL
    • FIRST MEDICAL SOURCE
    • DELTAMED
    • VIKYMED ITALIA SRL
    • CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.
    • MAIS INDIA
    • NARANG MEDICAL LIMITED
    • ZEBRA MEDICAL

第15章調查方法

第16章：鄰近及相關市場

  • 介紹
  • 限制

第17章附錄

Product Code: CH 9585

The elastomeric infusion pumps market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the forecast period.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million)
SegmentsType, Application, End-use Industry, and Region
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

The elastomeric infusion pumps market is projected for steady growth as healthcare providers and patients increasingly utilize portable, non-electronic devices for accurate, continuous drug administration. The increasing demand in oncology, pain management, anesthesia, and home care contributes to market growth, driven by the need for patient-centric, ambulatory, and simplified infusion solutions. These devices provide reliable and accurate medicine delivery without requiring batteries or complex circuitry, thereby improving patient mobility and compliance.

Elastomeric Infusion Pumps Market - IMG1

Regulatory entities, such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), as well as several regional health organizations, have implemented more stringent requirements for safety, quality, and biocompatibility. This is pushing manufacturers to develop new multi-chamber designs, flow control systems, and better elastomers. To mitigate medical waste, current advancements encompass real-time dosage monitoring, integration with intelligent monitoring systems, and the utilization of recyclable, eco-friendly materials.

"Pain Management accounted for the largest share in the elastomeric infusion pumps market in 2024."

Pain management accounted for the largest share of the elastomeric infusion pumps market in 2024, driven by their widespread use in surgical and chronic pain treatments. These pumps provide a continuous, controlled dosage of analgesics like morphine or fentanyl, ensuring efficient reduction of pain while reducing hospital stays. Their portability, user-friendliness, and capacity to deliver consistent drug infusion without technological components render them optimal for both inpatient and home-care environments. The rise in surgical procedures, along with an increased focus on patient comfort and mobility, enhances their use in pain treatment applications.

"Hospitals accounted for the largest share of the elastomeric infusion pumps market in 2024."

In 2024, hospitals represented the largest segment of the elastomeric infusion pumps market, driven by a significant need for reliable and continuous drug delivery systems across various therapies. These pumps are extensively used for postoperative analgesia, chemotherapy, and antibiotic delivery, providing continuous infusion that is independent of electronic components or external power sources. Their disposable and sterile design complies with hospital infection control requirements, thereby reducing the risk of cross-contamination and the need for device maintenance. Additionally, the increasing number of surgeries, the focus on expediting patient recovery, and patients' preference for less-expensive infusion solutions have all contributed to their growing prevalence in hospitals. Elastomeric pumps are important tools for modern hospital-based patient care as they are easy to use, safe, and accurate.

"North America dominated the regional market for elastomeric infusion pumps in 2024."

In 2024, the elastomeric infusion pumps market was primarily concentrated in North America due to an advanced healthcare system, widespread adoption of cutting-edge medical devices, and a heightened incidence of chronic conditions, such as cancer, cardiovascular disease, and diabetes. Many of the benefits in this region stem from strong reimbursement policies, enabling policies, and increasing outpatient and home care service patterns, all of which heavily promote the development of portable and simple-to-use infusion systems. The continued existence of market leaders in a good overall position, with ample development of conducive factors, created further opportunities for market leadership development. In addition, hospitals and specialist clinics continuously utilize elastomeric pumps to provide continuous, allowed, high-dose drug delivery for the management of pain and for post-surgery comfort, which creates both patient comfort and cost-saving measures against hospitalization.

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%

By Designation: Directors: 30%, Managers: 20%, and Others: 50%

By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa 20%

Notes: Others include sales, marketing, and product managers.

Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan) are covered in the report.

The study includes an in-depth competitive analysis of these key players in the elastomeric infusion pumps market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the elastomeric infusion pumps market based on type (Continuous Rate and Variable Rate), application (Pain Management, Antibiotics, Chemotherapy, and Other Applications), and end-use industry (Hospitals, Ambulatory Surgical Centers (ASCs), Home-care Settings, and Other End-use Industries). The report's scope encompasses detailed information regarding the drivers, restraints, challenges, and opportunities that influence the growth of the elastomeric infusion pumps market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, products offered, and key strategies, including partnerships, collaborations, mergers, acquisitions, and expansions, associated with the elastomeric infusion pumps market. This report covers a competitive analysis of upcoming startups in the elastomeric infusion pumps market ecosystem.

Reasons to Buy the Report

The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall elastomeric infusion pumps market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

  • Analysis of key drivers (rising prevalence of chronic diseases, growing shift to ambulatory and home-based care, and disposable and portable design), restraints (rising risks of incorrect drug delivery and performance variability, regulatory recalls on elastomeric pump reliability, and stringent regulatory approvals and compliance requirements), opportunities (rising healthcare advancements in emerging economies, and specialization for high-viscosity drugs and biologics), and challenges (intense competition with electronic infusion technologies and maintaining precision and safety in scaled elastomeric pump production).
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the elastomeric infusion pumps market.
  • Market Development: Comprehensive information about profitable markets - the report analyzes the elastomeric infusion pumps market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the elastomeric infusion pumps market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET
  • 3.2 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE AND COUNTRY
  • 3.3 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE
  • 3.4 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION
  • 3.5 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
  • 3.6 ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising prevalence of chronic diseases
      • 4.2.1.2 Growing shift to ambulatory and home-based care
      • 4.2.1.3 Disposable and portable design
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Rising risks of incorrect drug delivery and performance variability
      • 4.2.2.2 Regulatory recalls on elastomeric pump reliability
      • 4.2.2.3 Stringent regulatory approvals and compliance requirements
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Rising healthcare advancements in emerging economies
      • 4.2.3.2 Specialization for high-viscosity drugs and biologics
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Intense competition with electronic infusion technologies
      • 4.2.4.2 Maintaining precision and safety in scaled elastomeric pump production
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC ANALYSIS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECASTS
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF ELASTOMERIC INFUSION PUMPS, BY TYPE
    • 5.5.2 AVERAGE SELLING PRICE ANALYSIS, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 EXPORT SCENARIO (HS CODE 901890)
    • 5.6.2 IMPORT SCENARIO (HS CODE 901890)
  • 5.7 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • 5.8.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 MOBILITY ENHANCEMENT IN INFUSION THERAPY USING SUREFUSER+ PUMP
    • 5.10.2 COST-SAVING POTENTIAL OF ELASTOMERIC PUMPS IN POSTOPERATIVE PAIN THERAPY
    • 5.10.3 IMPROVED QUALITY OF LIFE IN CHEMOTHERAPY WITH SUREFUSER+ PUMP
  • 5.11 IMPACT OF 2025 US TARIFF: ELASTOMERIC INFUSION PUMPS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 China
      • 5.11.4.3 Europe
      • 5.11.4.4 Brazil
    • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 PRECISION FLOW CONTROL SYSTEMS AND MULTI-RATE DESIGNS
    • 6.1.2 ADVANCED MATERIALS FOR DRUG STABILITY
    • 6.1.3 ELASTOMERIC MEMBRANE FOR PRESSURE GENERATION
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 ANTIMICROBIAL AND BIOCOMPATIBLE MATERIALS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 SMART CONNECTIVITY AND IOT INTEGRATION
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
    • 6.4.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.4.2 MID-TERM (2027-2030) | EXPANSION & INTEGRATION
    • 6.4.3 LONG-TERM (2030-2035+) | MATURITY & AUTONOMOUS SYSTEMS
  • 6.5 PATENT ANALYSIS
    • 6.5.1 INTRODUCTION
    • 6.5.2 METHODOLOGY
    • 6.5.3 ELASTOMERIC INFUSION PUMPS MARKET, PATENT ANALYSIS, 2015-2024
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 INTEGRATION WITH DIGITAL HEALTH FOR REMOTE MONITORING
    • 6.6.2 EXPANSION INTO VETERINARY AMBULATORY CARE
    • 6.6.3 DELIVERY OF ADVANCED THERAPEUTICS LIKE BIOLOGICS AND GENE THERAPY
    • 6.6.4 BIOLUMINESCENT INDICATOR FILMS
  • 6.7 IMPACT OF AI/GEN AI ON ELASTOMERIC INFUSION PUMPS MARKET
    • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.2 BEST PRACTICES IN ELASTOMERIC INFUSION PUMP PROCESSING
    • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ELASTOMERIC INFUSION PUMPS MARKET
    • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN ELASTOMERIC INFUSION PUMPS MARKET
  • 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    • 6.8.1 UNIVERSITY OF MICHIGAN DEPLOYS DOSI-FUSER ELASTOMERIC INFUSION SYSTEM FOR HOME CHEMOTHERAPY
    • 6.8.2 PEDIATRIC HOME CHEMOTHERAPY (INTACT@HOME, CANADA)
    • 6.8.3 PALLIATIVE CARE AND END-OF-LIFE SYMPTOM MANAGEMENT (SOUTHERN ONTARIO, CANADA)

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF ELASTOMERIC INFUSION PUMPS
      • 7.2.1.1 Carbon impact reduction
      • 7.2.1.2 Eco-applications
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION

9 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 CONTINUOUS RATE
    • 9.2.1 DEMAND FOR PRECISE, PORTABLE, AND POWER-FREE DRUG DELIVERY IN OUTPATIENT CARE TO DRIVE MARKET
  • 9.3 VARIABLE RATE
    • 9.3.1 RISING NEED FOR PERSONALIZED AND ADJUSTABLE DRUG DELIVERY IN AMBULATORY CARE TO DRIVE DEMAND

10 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 CHEMOTHERAPY
    • 10.2.1 RISING CANCER INCIDENCE AND SHIFT TOWARD OUTPATIENT CHEMOTHERAPY DRIVING ADOPTION
  • 10.3 PAIN MANAGEMENT
    • 10.3.1 RISING PREVALENCE OF CHRONIC PAIN AND DEMAND FOR OUTPATIENT ANALGESIC DELIVERY TO SUPPORT MARKET GROWTH
  • 10.4 ANTIBIOTICS
    • 10.4.1 GROWTH OF OUTPATIENT ANTIBIOTIC THERAPY AND HOME-BASED CARE DRIVING ADOPTION
  • 10.5 OTHER APPLICATIONS

11 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY

  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS
    • 11.2.1 NEED FOR ENHANCING PATIENT CARE AND OPERATIONAL EFFICIENCY TO DRIVE MARKET
  • 11.3 AMBULATORY SURGICAL CENTERS (ASCS)
    • 11.3.1 OFFERS OPTIMIZED OUTPATIENT SURGICAL CARE WITH EFFICIENT DRUG DELIVERY
  • 11.4 HOMECARE SETTINGS
    • 11.4.1 INCREASING DEMAND FOR SAFE AND INDEPENDENT HOME- BASED CARE TO DRIVE MARKET
  • 11.5 OTHER END-USE INDUSTRIES

12 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 Rising cancer prevalence driving demand for continuous infusion therapies
    • 12.2.2 CANADA
      • 12.2.2.1 Aging population and increasing cancer cases propelling growth
    • 12.2.3 MEXICO
      • 12.2.3.1 Government health initiatives and rising chronic disease burden to boost demand
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Strong healthcare infrastructure and growing preference for home-based care to drive demand
    • 12.3.2 FRANCE
      • 12.3.2.1 Rising oncology cases and preference for outpatient care to boost market growth
    • 12.3.3 UK
      • 12.3.3.1 Strong healthcare infrastructure and rising cancer burden driving demand
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing chronic pain burden driving adoption
    • 12.3.5 SPAIN
      • 12.3.5.1 Rising cancer incidence and aging population fueling demand
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Growing hospital infrastructure and rising outpatient care fueling adoption
    • 12.4.2 JAPAN
      • 12.4.2.1 Growing aging population to support market growth
    • 12.4.3 INDIA
      • 12.4.3.1 Expanding cancer care infrastructure and home-based treatment driving adoption
    • 12.4.4 SOUTH KOREA
      • 12.4.4.1 Rising healthcare needs and technological integration to accelerate market growth
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Increased healthcare spending driving market growth
    • 12.4.6 REST OF ASIA PACIFIC
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Government healthcare programs and expanding chronic care infrastructure propelling adoption
    • 12.5.2 ARGENTINA
      • 12.5.2.1 Expanding healthcare infrastructure and chronic disease management boosting adoption
    • 12.5.3 REST OF SOUTH AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GCC COUNTRIES
      • 12.6.1.1 Saudi Arabia
        • 12.6.1.1.1 Healthcare transformation and localization initiatives under Vision 2030 to accelerate demand
      • 12.6.1.2 UAE
        • 12.6.1.2.1 Expanding healthcare infrastructure fueling adoption of elastomeric infusion pumps
      • 12.6.1.3 Rest of GCC Countries
    • 12.6.2 SOUTH AFRICA
      • 12.6.2.1 National health insurance implementation and chronic care initiatives to fuel growth
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYERS' STRATEGIES
  • 13.3 MARKET SHARE ANALYSIS
  • 13.4 REVENUE ANALYSIS
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.6 PRODUCT/BRAND COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Regional footprint
      • 13.7.5.3 Type footprint
      • 13.7.5.4 Application footprint
      • 13.7.5.5 End-use industry footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.8.5.1 Detailed list of key startups/SMEs
      • 13.8.5.2 Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 DEALS
    • 13.9.2 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 BAXTER
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 MnM view
        • 14.1.1.3.1 Key strengths
        • 14.1.1.3.2 Strategic choices
        • 14.1.1.3.3 Weaknesses and competitive threats
    • 14.1.2 B. BRAUN SE
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 NIPRO
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Deals
        • 14.1.3.3.2 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 AVNS
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Key strengths
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 VYGON
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
        • 14.1.5.3.2 Expansions
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 WOOYOUNG MEDICAL CO., LTD.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 MnM view
    • 14.1.7 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
      • 14.1.7.4 MnM view
    • 14.1.8 AMBU A/S
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Expansions
      • 14.1.8.4 MnM view
    • 14.1.9 PALEX
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
      • 14.1.9.4 MnM view
    • 14.1.10 DAIKEN MEDICAL CO., LTD.
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
      • 14.1.10.3 MnM view
  • 14.2 OTHER PLAYERS
    • 14.2.1 PROMECON GMBH
    • 14.2.2 S&S MED
    • 14.2.3 EPIC MEDICAL
    • 14.2.4 MULTIMEDICAL S.R.L.
    • 14.2.5 TECNOLINE S.P.A.
    • 14.2.6 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.
    • 14.2.7 ACE MEDICAL
    • 14.2.8 GAMASTECH SRL
    • 14.2.9 FIRST MEDICAL SOURCE
    • 14.2.10 DELTAMED
    • 14.2.11 VIKYMED ITALIA SRL
    • 14.2.12 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.
    • 14.2.13 MAIS INDIA
    • 14.2.14 NARANG MEDICAL LIMITED
    • 14.2.15 ZEBRA MEDICAL

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Key industry insights
  • 15.2 MARKET SIZE ESTIMATION
  • 15.3 BASE NUMBER CALCULATION
    • 15.3.1 DEMAND-SIDE APPROACH
    • 15.3.2 SUPPLY-SIDE APPROACH
  • 15.4 MARKET FORECAST APPROACH
    • 15.4.1 SUPPLY SIDE
    • 15.4.2 DEMAND SIDE
  • 15.5 DATA TRIANGULATION
  • 15.6 FACTOR ANALYSIS
  • 15.7 RESEARCH ASSUMPTIONS
  • 15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT

16 ADJACENT & RELATED MARKETS

  • 16.1 INTRODUCTION
  • 16.2 LIMITATIONS
    • 16.2.1 INFUSION PUMPS MARKET
      • 16.2.1.1 Market definition
      • 16.2.1.2 Infusion pumps market, by product
      • 16.2.1.3 Infusion pumps market, by application
      • 16.2.1.4 Infusion pumps market, by setting
      • 16.2.1.5 Infusion pumps market, by region

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ELASTOMERIC INFUSION PUMPS MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 2 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021-2028 (USD TRILLION)
  • TABLE 3 ELASTOMERIC INFUSION PUMPS MARKET: ROLES OF COMPANIES IN ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD/UNIT)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030 (USD/UNIT)
  • TABLE 6 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 8 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025-2026
  • TABLE 9 ELASTOMERIC INFUSION PUMPS MARKET: LIST OF KEY PATENTS, 2022-2024
  • TABLE 10 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 11 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 12 ELASTOMERIC INFUSION PUMPS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 18 GLOBAL INDUSTRY STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
  • TABLE 19 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY (%)
  • TABLE 21 KEY BUYING CRITERIA, BY END-USE INDUSTRY
  • TABLE 22 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
  • TABLE 23 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 24 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 25 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 26 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 31 US: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 32 US: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 33 US: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 34 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 36 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 38 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 39 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 42 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 43 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 44 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 46 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 47 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 49 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 50 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 51 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 52 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 53 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 54 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 55 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 56 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 57 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 58 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 59 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 61 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 66 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 67 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 68 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 69 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 71 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 72 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 74 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 75 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 77 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 78 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 81 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 84 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 87 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 88 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 90 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 93 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 94 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 101 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 103 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 104 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 106 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 107 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 109 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 110 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 112 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 113 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 115 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 116 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 119 ELASTOMERIC INFUSION PUMPS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020-OCTOBER 2025
  • TABLE 120 ELASTOMERIC INFUSION PUMPS MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 121 ELASTOMERIC INFUSION PUMPS MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 122 ELASTOMERIC INFUSION PUMPS MARKET: TYPE FOOTPRINT, 2024
  • TABLE 123 ELASTOMERIC INFUSION PUMPS MARKET: APPLICATION FOOTPRINT, 2024
  • TABLE 124 ELASTOMERIC INFUSION PUMPS MARKET: END-USE INDUSTRY FOOTPRINT, 2024
  • TABLE 125 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
  • TABLE 126 ELASTOMERIC INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
  • TABLE 127 ELASTOMERIC INFUSION PUMPS MARKET: DEALS, JANUARY 2020-OCTOBER 2025
  • TABLE 128 ELASTOMERIC INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2020-OCTOBER 2025
  • TABLE 129 BAXTER: COMPANY OVERVIEW
  • TABLE 130 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 131 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 132 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 133 B. BRAUN SE: DEALS
  • TABLE 134 NIPRO: COMPANY OVERVIEW
  • TABLE 135 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 136 NIPRO: DEALS
  • TABLE 137 NIPRO: EXPANSIONS
  • TABLE 138 AVNS: COMPANY OVERVIEW
  • TABLE 139 AVNS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 140 VYGON: COMPANY OVERVIEW
  • TABLE 141 VYGON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 142 VYGON: DEALS
  • TABLE 143 VYGON: EXPANSIONS
  • TABLE 144 WOOYOUNG MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 145 WOOYOUNG MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 146 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
  • TABLE 147 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  • TABLE 148 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: DEALS
  • TABLE 149 AMBU A/S: COMPANY OVERVIEW
  • TABLE 150 AMBU A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 151 AMBU A/S: EXPANSIONS
  • TABLE 152 PALEX: COMPANY OVERVIEW
  • TABLE 153 PALEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 154 PALEX: DEALS
  • TABLE 155 DAIKEN MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 156 DAIKEN MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 157 PROMECON GMBH: COMPANY OVERVIEW
  • TABLE 158 S&S MED: COMPANY OVERVIEW
  • TABLE 159 EPIC MEDICAL: COMPANY OVERVIEW
  • TABLE 160 MULTIMEDICAL S.R.L.: COMPANY OVERVIEW
  • TABLE 161 TECNOLINE S.P.A.: COMPANY OVERVIEW
  • TABLE 162 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW
  • TABLE 163 ACE MEDICAL: COMPANY OVERVIEW
  • TABLE 164 GAMASTECH SRL: COMPANY OVERVIEW
  • TABLE 165 FIRST MEDICAL SOURCE: COMPANY OVERVIEW
  • TABLE 166 DELTAMED: COMPANY OVERVIEW
  • TABLE 167 VIKYMED ITALIA SRL: COMPANY OVERVIEW
  • TABLE 168 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
  • TABLE 169 MAIS INDIA: COMPANY OVERVIEW
  • TABLE 170 NARANG MEDICAL LIMITED: COMPANY OVERVIEW
  • TABLE 171 ZEBRA MEDICAL: COMPANY OVERVIEW
  • TABLE 172 INFUSION PUMPS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • TABLE 173 INFUSION PUMPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • TABLE 174 INFUSION PUMPS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • TABLE 175 INFUSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

  • FIGURE 1 ELASTOMERIC INFUSION PUMPS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 GLOBAL ELASTOMERIC INFUSION PUMPS MARKET, 2023-2030
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET (2020-2025)
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN ELASTOMERIC INFUSION PUMPS MARKET, 2024
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 HIGH DEMAND IN HOSPITALS AND HOMECARE SETTINGS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 9 US DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN NORTH AMERICA
  • FIGURE 10 CONTINUOUS RATE SEGMENT DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 11 PAIN MANAGEMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 12 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 13 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 ELASTOMERIC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 US CANCER SURVIVORS (MALE & FEMALE) BY YEARS SINCE DIAGNOSIS, AS OF JANUARY 2025
  • FIGURE 16 ELASTOMERIC INFUSION PUMPS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 ELASTOMERIC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 18 ELASTOMERIC INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024
  • FIGURE 20 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030
  • FIGURE 21 EXPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 22 IMPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2018-2024
  • FIGURE 25 LIST OF MAJOR PATENTS FOR ELASTOMERIC INFUSION PUMPS, 2015-2024
  • FIGURE 26 MAJOR PATENTS APPLIED AND GRANTED RELATED TO ELASTOMERIC INFUSION PUMPS, BY COUNTRY/REGION, 2015-2024
  • FIGURE 27 ELASTOMERIC INFUSION PUMPS MARKET DECISION-MAKING FACTORS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY
  • FIGURE 29 KEY BUYING CRITERIA, BY END-USE INDUSTRY
  • FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • FIGURE 31 CONTINUOUS RATE SEGMENT TO DOMINATE ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
  • FIGURE 32 PAIN MANAGEMENT TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
  • FIGURE 33 HOSPITALS TO BE LARGEST END-USE INDUSTRY OF ELASTOMERIC INFUSION PUMPS IN 2025
  • FIGURE 34 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 35 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
  • FIGURE 36 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
  • FIGURE 37 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
  • FIGURE 38 ELASTOMERIC INFUSION PUMPS: MARKET SHARE ANALYSIS, 2024
  • FIGURE 39 ELASTOMERIC INFUSION PUMPS MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020-2024
  • FIGURE 40 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY VALUATION, 2024
  • FIGURE 41 ELASTOMERIC INFUSION PUMPS MARKET: FINANCIAL MATRIX: EV/ EBITDA RATIO, 2024
  • FIGURE 42 ELASTOMERIC INFUSION PUMPS MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA, 2024
  • FIGURE 43 ELASTOMERIC INFUSION PUMPS MARKET: PRODUCT/BRAND COMPARISON
  • FIGURE 44 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 46 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 BAXTER: COMPANY SNAPSHOT
  • FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 49 NIPRO: COMPANY SNAPSHOT
  • FIGURE 50 AVNS: COMPANY SNAPSHOT
  • FIGURE 51 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 52 AMBU A/S: COMPANY SNAPSHOT
  • FIGURE 53 DAIKEN MEDICAL CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 54 ELASTOMERIC INFUSION PUMPS MARKET: RESEARCH DESIGN
  • FIGURE 55 BREAKDOWN OF INTERVIEWS WITH EXPERTS
  • FIGURE 56 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 57 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 58 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 1
  • FIGURE 59 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 2
  • FIGURE 60 ELASTOMERIC INFUSION PUMPS MARKET: DATA TRIANGULATION